ERYTHROPLAKIA
Clinical trials for ERYTHROPLAKIA explained in plain language.
Never miss a new study
Get alerted when new ERYTHROPLAKIA trials appear
Sign up with your email to follow new studies for ERYTHROPLAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-Dark mouth scans could catch cancer early
Diagnosis OngoingThis study tests whether special lights and cameras can help find early signs of mouth cancer in people at high risk. About 338 participants with precancerous spots or conditions like Fanconi anemia will have their mouths examined with fluorescence imaging, which makes abnormal c…
Matched conditions: ERYTHROPLAKIA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Could a common diabetes drug stop oral cancer before it starts?
Prevention OngoingThis phase 2 trial tests whether metformin, a widely used diabetes drug, can prevent oral cancer in 26 people with precancerous mouth lesions (leukoplakia or erythroplakia). Participants take metformin by mouth, and researchers check if the lesions shrink or disappear. The goal i…
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
Can a diabetes drug stop oral cancer before it starts?
Prevention OngoingThis study tests whether metformin, a common diabetes drug, can prevent oral cancer in people with precancerous white or red patches in the mouth. About 34 participants will receive either metformin or a placebo for several months. Researchers will check if the patches shrink or …
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated Jun 27, 2026 12:09 UTC